NKX2-8 and ovarian carcinoma: The combination of perhexiline and cisplatin markedly reduced the growth of an epithelial ovarian cancer (EOC) cell line xenograft bearing a deletion in the NK2 homeobox 8 (NKX2-8+/−) gene.